This topic contains a solution. Click here to go to the answer

Author Question: Which of the following was developed by the U.S. Employment Service to measure occupational ... (Read 89 times)

mia

  • Hero Member
  • *****
  • Posts: 564
Which of the following was developed by the U.S. Employment Service to measure occupational aptitude?
 
  a. IPAT Culture Fair Intelligence Test
  b. Wonderlic Personnel Test
  c. General Aptitude Test Battery
  d. Raven Progressive Matrices

Question 2

The Armed Services Vocational Aptitude Battery
 
  a. has poor psychometric characteristics.
  b. is not a valid predictor of training performance.
  c. does not have adequate norming information.
  d. now has a computerized adaptive version.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ecox1012

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

c

Answer to Question 2

d




mia

  • Member
  • Posts: 564
Reply 2 on: Jun 19, 2018
Thanks for the timely response, appreciate it


mammy1697

  • Member
  • Posts: 341
Reply 3 on: Yesterday
Gracias!

 

Did you know?

About one in five American adults and teenagers have had a genital herpes infection—and most of them don't know it. People with genital herpes have at least twice the risk of becoming infected with HIV if exposed to it than those people who do not have genital herpes.

Did you know?

It is widely believed that giving a daily oral dose of aspirin to heart attack patients improves their chances of survival because the aspirin blocks the formation of new blood clots.

Did you know?

Amphetamine poisoning can cause intravascular coagulation, circulatory collapse, rhabdomyolysis, ischemic colitis, acute psychosis, hyperthermia, respiratory distress syndrome, and pericarditis.

Did you know?

More than 50% of American adults have oral herpes, which is commonly known as "cold sores" or "fever blisters." The herpes virus can be active on the skin surface without showing any signs or causing any symptoms.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library